Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 24,302 | 23,387 | 19,868 | 18,123 | 11,504 |
| Operating Income | -24,302 | -23,387 | -19,868 | -18,123 | -11,504 |
| Other Income | 370 | -53 | 31 | -282 | -772 |
| Pre-tax Income | -23,932 | -23,440 | -19,837 | -18,405 | -12,276 |
| Net Income Continuous | -23,932 | -23,440 | -19,837 | -18,405 | -12,276 |
| Net Income | $-23,932 | $-23,440 | $-19,837 | $-18,405 | $-12,276 |
| EPS Basic Total Ops | -0.51 | 8.28 | -0.43 | -3.63 | -7.18 |
| EPS Basic Continuous Ops | -0.51 | 8.29 | -0.43 | -3.63 | -7.18 |
| EPS Diluted Total Ops | -0.51 | 8.28 | -0.43 | -3.63 | -7.18 |
| EPS Diluted Continuous Ops | -0.51 | 8.29 | -0.43 | -3.63 | -7.18 |
| EBITDA(a) | $-23,549 | $-22,578 | $-19,286 | $-17,656 | $-11,230 |